Page C, Benaim S, Lappin F
Academic Department of Psychiatry, Royal Free Hospital, London.
Br J Psychiatry. 1987 Feb;150:175-9. doi: 10.1192/bjp.150.2.175.
Patients suffering from unipolar and bipolar affective illness, who began treatment with prophylactic lithium carbonate during a 5-year period, were followed up and 59 out of 101 interviewed. Most had been taking lithium for at least 13 years: 49% had a complete remission, 41% a partial but significant response, and 10% no response. No specific individual or illness factor was found to correlate with favourable outcome, and no correlation between average serum lithium level and outcome. No side-effects could be associated specifically with the long-term use of lithium, but there was a surprisingly high incidence of clinical hypothyroidism.
在5年期间开始使用碳酸锂进行预防性治疗的单相和双相情感障碍患者接受了随访,对101名患者进行了访谈,其中59名完成访谈。大多数患者服用锂盐至少13年:49%完全缓解,41%部分但有显著反应,10%无反应。未发现与良好预后相关的特定个体或疾病因素,且平均血清锂水平与预后之间无相关性。长期使用锂盐未发现有特定的副作用,但临床甲状腺功能减退症的发生率惊人地高。